Factors Associated with Recurrent Heart Failure during Incorporating SGLT2 Inhibitors in Patients Hospitalized for Acute Decompensated Heart Failure

Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) reduce the risk of hospitalization for heart failure (HF) or death from cardiovascular causes among patients with chronic HF. However, little is known about the specific factors associated with clinical events during SGLT2i therapy in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagaito, Masaki, Imamura, Teruhiko, Joho, Shuji, Ushijima, Ryuichi, Nakamura, Makiko, Kinugawa, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457103/
https://www.ncbi.nlm.nih.gov/pubmed/36078956
http://dx.doi.org/10.3390/jcm11175027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457103/
https://www.ncbi.nlm.nih.gov/pubmed/36078956
http://dx.doi.org/10.3390/jcm11175027

Ejemplares similares